Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Andover, Massachusetts 01810


The purpose of this study is to compare the safety and efficacy of RX-10045 to placebo for the treatment of the signs and symptoms of dry eye.


Inclusion Criteria: - Be at least 18 years of age; - Have provided written informed consent; - Have a history of dry eye for at least 6 months prior to enrollment; - Have a history of use or desire to use eye drops for dry eye symptoms within the past 6 months; - Demonstrate a response when exposed to the CAE. Exclusion Criteria: - Have an on-going ocular infection, or active ocular inflammation - Have worn contact lenses within 72 hours of Visit 1 or have anticipated use of contact lenses during the study; - Have contact lens-induced dry eye; - Have previously had laser in situ keratomileusis (LASIK) surgery; - Be using or have anticipated use of temporary punctual plugs during the study; - Have best corrected visual acuity > +0.7 in both eyes; - Be a woman who is pregnant, nursing or planning a pregnancy; - Have a known allergy and/or sensitivity to the test article or its components; - Be currently using any medication known to cause ocular drying that is not used on a stable dosing regimen for at least 30 days



Primary Contact:

Principal Investigator
Gail Torkildsen, MD
Ophthalmic Research Associates, Andover, MA

Backup Contact:


Location Contact:

Andover, Massachusetts 01810
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.